Sana Biotechnology, Inc.

Sana Biotechnology, Inc.verified

SANA

Price:

$5.51

Market Cap:

$1.22B

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia;...[Read more]

Industry

Biotechnology

IPO Date

2021-02-04

Stock Exchange

NASDAQ

Ticker

SANA

The PE Ratio as of June 2024 (TTM) for Sana Biotechnology, Inc. (SANA) is -3.62

According to Sana Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.62. This represents a change of -107.88% compared to the average of 45.94 of the last 4 quarters.

Sana Biotechnology, Inc. (SANA) Historical PE Ratio (quarterly & annually)

How has SANA PE Ratio performed in the past?

The mean historical PE Ratio of Sana Biotechnology, Inc. over the last ten years is -14.50. The current -3.62 PE Ratio has changed 2.40% with respect to the historical average. Over the past ten years (40 quarters), SANA's PE Ratio was at its highest in in the September 2023 quarter at 193.68. The PE Ratio was at its lowest in in the March 2020 quarter at -34.77.

Quarterly (TTM)
Annual

Average

-14.50

Median

-5.14

Minimum

-50.28

Maximum

0

Sana Biotechnology, Inc. (SANA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sana Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0.34%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -50.28

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.800.34%
2022-2.79-62.69%
2021-7.49-68.31%
2020-23.62-53.02%
2019-50.28-Infinity%

Sana Biotechnology, Inc. (SANA) Average PE Ratio

How has SANA PE Ratio performed in the past?

The current PE Ratio of Sana Biotechnology, Inc. (SANA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.36

5-year avg

-17.40

10-year avg

-14.50

Sana Biotechnology, Inc. (SANA) PE Ratio vs. Peers

How is SANA’s PE Ratio compared to its peers?

Sana Biotechnology, Inc.’s PE Ratio is greater than Olema Pharmaceuticals, Inc. (-6.51), greater than Cullinan Oncology, Inc. (-5.66), less than aTyr Pharma, Inc. (-2.33), less than Zentalis Pharmaceuticals, Inc. (-1.54), less than X4 Pharmaceuticals, Inc. (-1.57), less than Galera Therapeutics, Inc. (-0.10), greater than Terns Pharmaceuticals, Inc. (-5.91), greater than Day One Biopharmaceuticals, Inc. (-5.68), less than HOOKIPA Pharma Inc. (-1.70), greater than Revolution Medicines, Inc. (-13.00), greater than Blueprint Medicines Corporation (-22.26), greater than Kymera Therapeutics, Inc. (-14.64), less than Monte Rosa Therapeutics, Inc. (-1.61), less than Nkarta, Inc. (-2.40), less than Lyell Immunopharma, Inc. (-2.28), less than Generation Bio Co. (-1.08), greater than Mirati Therapeutics, Inc. (-5.32), less than Amylyx Pharmaceuticals, Inc. (-1.70), greater than Apellis Pharmaceuticals, Inc. (-11.22),

Build a custom stock screener for Sana Biotechnology, Inc. (SANA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sana Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sana Biotechnology, Inc. (SANA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sana Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sana Biotechnology, Inc.'s PE Ratio?

How is the PE Ratio calculated for Sana Biotechnology, Inc. (SANA)?

What is the highest PE Ratio for Sana Biotechnology, Inc. (SANA)?

What is the 3-year average PE Ratio for Sana Biotechnology, Inc. (SANA)?

What is the 5-year average PE Ratio for Sana Biotechnology, Inc. (SANA)?

How does the current PE Ratio for Sana Biotechnology, Inc. (SANA) compare to its historical average?